Proton Therapy System (ProBeam)

RADIATION2 trials

Sponsors

Varian, a Siemens Healthineers Company, Guangzhou Concord Cancer Center

Conditions

Nasopharyngeal Carcinoma (NPC)Tumor, Solid

Unknown Phase

Varian ProBeam Proton Therapy System China Clinical Trial (Hefei)

CompletedNCT05463055

Varian, a Siemens Healthineers CompanyTumor, Solid

Start: 2021-12-26End: 2022-11-03Updated: 2024-11-15

A Multicenter, Prospective, Phase III Clinical Study of Proton Intensity-modulated Radiotherapy Versus Photon Intensity-modulated Radiotherapy for Untreated Non-metastatic Nasopharyngeal Carcinoma

Not yet recruitingNCT07578727

Guangzhou Concord Cancer CenterNasopharyngeal Carcinoma (NPC)

Start: 2026-07-01End: 2028-12-30Target: 504Updated: 2026-07-08